ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Path Fertility, a Salt Lake City molecular diagnostics company, received a $2M SBIR grant from the NIH on 04/11/2026. The funds support developing an epigenetic diagnostic for non-obstructive azoospermia and its associated cancer risk.
Tap to vote and see what everyone thinks.
Summary by ByteBrief